-
Notifications
You must be signed in to change notification settings - Fork 0
/
Copy pathmost_recent_publications_2017-04-19.xml
13759 lines (13684 loc) · 717 KB
/
most_recent_publications_2017-04-19.xml
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
486
487
488
489
490
491
492
493
494
495
496
497
498
499
500
501
502
503
504
505
506
507
508
509
510
511
512
513
514
515
516
517
518
519
520
521
522
523
524
525
526
527
528
529
530
531
532
533
534
535
536
537
538
539
540
541
542
543
544
545
546
547
548
549
550
551
552
553
554
555
556
557
558
559
560
561
562
563
564
565
566
567
568
569
570
571
572
573
574
575
576
577
578
579
580
581
582
583
584
585
586
587
588
589
590
591
592
593
594
595
596
597
598
599
600
601
602
603
604
605
606
607
608
609
610
611
612
613
614
615
616
617
618
619
620
621
622
623
624
625
626
627
628
629
630
631
632
633
634
635
636
637
638
639
640
641
642
643
644
645
646
647
648
649
650
651
652
653
654
655
656
657
658
659
660
661
662
663
664
665
666
667
668
669
670
671
672
673
674
675
676
677
678
679
680
681
682
683
684
685
686
687
688
689
690
691
692
693
694
695
696
697
698
699
700
701
702
703
704
705
706
707
708
709
710
711
712
713
714
715
716
717
718
719
720
721
722
723
724
725
726
727
728
729
730
731
732
733
734
735
736
737
738
739
740
741
742
743
744
745
746
747
748
749
750
751
752
753
754
755
756
757
758
759
760
761
762
763
764
765
766
767
768
769
770
771
772
773
774
775
776
777
778
779
780
781
782
783
784
785
786
787
788
789
790
791
792
793
794
795
796
797
798
799
800
801
802
803
804
805
806
807
808
809
810
811
812
813
814
815
816
817
818
819
820
821
822
823
824
825
826
827
828
829
830
831
832
833
834
835
836
837
838
839
840
841
842
843
844
845
846
847
848
849
850
851
852
853
854
855
856
857
858
859
860
861
862
863
864
865
866
867
868
869
870
871
872
873
874
875
876
877
878
879
880
881
882
883
884
885
886
887
888
889
890
891
892
893
894
895
896
897
898
899
900
901
902
903
904
905
906
907
908
909
910
911
912
913
914
915
916
917
918
919
920
921
922
923
924
925
926
927
928
929
930
931
932
933
934
935
936
937
938
939
940
941
942
943
944
945
946
947
948
949
950
951
952
953
954
955
956
957
958
959
960
961
962
963
964
965
966
967
968
969
970
971
972
973
974
975
976
977
978
979
980
981
982
983
984
985
986
987
988
989
990
991
992
993
994
995
996
997
998
999
1000
<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2017//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_170101.dtd">
<PubmedArticleSet>
<PubmedArticle>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">27801980</PMID>
<DateCreated>
<Year>2016</Year>
<Month>11</Month>
<Day>01</Day>
</DateCreated>
<DateCompleted>
<Year>2017</Year>
<Month>04</Month>
<Day>03</Day>
</DateCompleted>
<DateRevised>
<Year>2017</Year>
<Month>04</Month>
<Day>03</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1755-0998</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>17</Volume>
<Issue>1</Issue>
<PubDate>
<Year>2017</Year>
<Month>Jan</Month>
</PubDate>
</JournalIssue>
<Title>Molecular ecology resources</Title>
<ISOAbbreviation>Mol Ecol Resour</ISOAbbreviation>
</Journal>
<ArticleTitle>phylodyn: an R package for phylodynamic simulation and inference.</ArticleTitle>
<Pagination>
<MedlinePgn>96-100</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1111/1755-0998.12630</ELocationID>
<Abstract>
<AbstractText>We introduce phylodyn, an r package for phylodynamic analysis based on gene genealogies. The package's main functionality is Bayesian nonparametric estimation of effective population size fluctuations over time. Our implementation includes several Markov chain Monte Carlo-based methods and an integrated nested Laplace approximation-based approach for phylodynamic inference that have been developed in recent years. Genealogical data describe the timed ancestral relationships of individuals sampled from a population of interest. Here, individuals are assumed to be sampled at the same point in time (isochronous sampling) or at different points in time (heterochronous sampling); in addition, sampling events can be modelled with preferential sampling, which means that the intensity of sampling events is allowed to depend on the effective population size trajectory. We assume the coalescent and the sequentially Markov coalescent processes as generative models of genealogies. We include several coalescent simulation functions that are useful for testing our phylodynamics methods via simulation studies. We compare the performance and outputs of various methods implemented in phylodyn and outline their strengths and weaknesses. r package phylodyn is available at https://github.com/mdkarcher/phylodyn.</AbstractText>
<CopyrightInformation>© 2016 John Wiley & Sons Ltd.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Karcher</LastName>
<ForeName>Michael D</ForeName>
<Initials>MD</Initials>
<AffiliationInfo>
<Affiliation>Department of Statistics, University of Washington, Seattle, WA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Palacios</LastName>
<ForeName>Julia A</ForeName>
<Initials>JA</Initials>
<AffiliationInfo>
<Affiliation>Department of Statistics, Stanford University, Stanford, CA, USA.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Department of Biomedical Data Science, Stanford University, Stanford, CA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lan</LastName>
<ForeName>Shiwei</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Statistics, University of Warwick, Coventry, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Minin</LastName>
<ForeName>Vladimir N</ForeName>
<Initials>VN</Initials>
<AffiliationInfo>
<Affiliation>Department of Statistics, University of Washington, Seattle, WA, USA.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Department of Biology, University of Washington, Seattle, WA, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R01 AI107034</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U54 GM111274</GrantID>
<Acronym>GM</Acronym>
<Agency>NIGMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2016</Year>
<Month>11</Month>
<Day>21</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Mol Ecol Resour</MedlineTA>
<NlmUniqueID>101465604</NlmUniqueID>
<ISSNLinking>1755-098X</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D056808" MajorTopicYN="N">Biostatistics</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D019295" MajorTopicYN="N">Computational Biology</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D003198" MajorTopicYN="Y">Computer Simulation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005828" MajorTopicYN="N">Genetics, Population</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011157" MajorTopicYN="Y">Population Dynamics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012984" MajorTopicYN="Y">Software</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="Y">Inla</Keyword>
<Keyword MajorTopicYN="Y">Mcmc</Keyword>
<Keyword MajorTopicYN="Y">evolutionary theory</Keyword>
<Keyword MajorTopicYN="Y">population dynamics</Keyword>
<Keyword MajorTopicYN="Y">population genetics - theoretical</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2016</Year>
<Month>06</Month>
<Day>10</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>2016</Year>
<Month>10</Month>
<Day>18</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2016</Year>
<Month>10</Month>
<Day>20</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2016</Year>
<Month>11</Month>
<Day>2</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2017</Year>
<Month>4</Month>
<Day>4</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2016</Year>
<Month>11</Month>
<Day>2</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">27801980</ArticleId>
<ArticleId IdType="doi">10.1111/1755-0998.12630</ArticleId>
</ArticleIdList>
</PubmedData>
</PubmedArticle>
<PubmedArticle>
<MedlineCitation Status="In-Process" Owner="NLM">
<PMID Version="1">28053012</PMID>
<DateCreated>
<Year>2017</Year>
<Month>01</Month>
<Day>05</Day>
</DateCreated>
<DateRevised>
<Year>2017</Year>
<Month>04</Month>
<Day>03</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1537-1719</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>34</Volume>
<Issue>1</Issue>
<PubDate>
<Year>2017</Year>
<Month>Jan</Month>
</PubDate>
</JournalIssue>
<Title>Molecular biology and evolution</Title>
<ISOAbbreviation>Mol. Biol. Evol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Phylogenetic Tools for Generalized HIV-1 Epidemics: Findings from the PANGEA-HIV Methods Comparison.</ArticleTitle>
<Pagination>
<MedlinePgn>185-203</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1093/molbev/msw217</ELocationID>
<Abstract>
<AbstractText>Viral phylogenetic methods contribute to understanding how HIV spreads in populations, and thereby help guide the design of prevention interventions. So far, most analyses have been applied to well-sampled concentrated HIV-1 epidemics in wealthy countries. To direct the use of phylogenetic tools to where the impact of HIV-1 is greatest, the Phylogenetics And Networks for Generalized HIV Epidemics in Africa (PANGEA-HIV) consortium generates full-genome viral sequences from across sub-Saharan Africa. Analyzing these data presents new challenges, since epidemics are principally driven by heterosexual transmission and a smaller fraction of cases is sampled. Here, we show that viral phylogenetic tools can be adapted and used to estimate epidemiological quantities of central importance to HIV-1 prevention in sub-Saharan Africa. We used a community-wide methods comparison exercise on simulated data, where participants were blinded to the true dynamics they were inferring. Two distinct simulations captured generalized HIV-1 epidemics, before and after a large community-level intervention that reduced infection levels. Five research groups participated. Structured coalescent modeling approaches were most successful: phylogenetic estimates of HIV-1 incidence, incidence reductions, and the proportion of transmissions from individuals in their first 3 months of infection correlated with the true values (Pearson correlation > 90%), with small bias. However, on some simulations, true values were markedly outside reported confidence or credibility intervals. The blinded comparison revealed current limits and strengths in using HIV phylogenetics in challenging settings, provided benchmarks for future methods' development, and supports using the latest generation of phylogenetic tools to advance HIV surveillance and prevention.</AbstractText>
<CopyrightInformation>© The Author 2016. Published by Oxford University Press on behalf of the Society for Molecular Biology and Evolution.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Ratmann</LastName>
<ForeName>Oliver</ForeName>
<Initials>O</Initials>
<AffiliationInfo>
<Affiliation>Department of Infectious Disease Epidemiology, MRC Centre for Outbreak Analyses and Modelling, School of Public Health, Imperial College London, London, United Kingdom oliver.ratmann@imperial.ac.uk.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hodcroft</LastName>
<ForeName>Emma B</ForeName>
<Initials>EB</Initials>
<AffiliationInfo>
<Affiliation>School of Biological Sciences, Institute of Evolutionary Biology, University of Edinburgh, Edinburgh, United Kingdom.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pickles</LastName>
<ForeName>Michael</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Infectious Disease Epidemiology, MRC Centre for Outbreak Analyses and Modelling, School of Public Health, Imperial College London, London, United Kingdom.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cori</LastName>
<ForeName>Anne</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Infectious Disease Epidemiology, MRC Centre for Outbreak Analyses and Modelling, School of Public Health, Imperial College London, London, United Kingdom.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hall</LastName>
<ForeName>Matthew</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>School of Biological Sciences, Institute of Evolutionary Biology, University of Edinburgh, Edinburgh, United Kingdom.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Nuffield Department of Medicine, Li Ka Shing Centre for Health Information and Discovery, Oxford Big Data Institute, University of Oxford, Oxford, United Kingdom.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lycett</LastName>
<ForeName>Samantha</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>School of Biological Sciences, Institute of Evolutionary Biology, University of Edinburgh, Edinburgh, United Kingdom.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>The Roslin Institute, University of Edinburgh, Edinburgh, United Kingdom.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Colijn</LastName>
<ForeName>Caroline</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Department of Mathematics, Imperial College London, London, United Kingdom.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dearlove</LastName>
<ForeName>Bethany</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Department of Veterinary Medicine, Cambridge Veterinary School, Cambridge, United Kingdom.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Didelot</LastName>
<ForeName>Xavier</ForeName>
<Initials>X</Initials>
<AffiliationInfo>
<Affiliation>Department of Infectious Disease Epidemiology, MRC Centre for Outbreak Analyses and Modelling, School of Public Health, Imperial College London, London, United Kingdom.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Frost</LastName>
<ForeName>Simon</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Veterinary Medicine, Cambridge Veterinary School, Cambridge, United Kingdom.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hossain</LastName>
<ForeName>A S Md Mukarram</ForeName>
<Initials>AS</Initials>
<AffiliationInfo>
<Affiliation>Department of Veterinary Medicine, Cambridge Veterinary School, Cambridge, United Kingdom.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Joy</LastName>
<ForeName>Jeffrey B</ForeName>
<Initials>JB</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, University of British Columbia, Vancouver, BC, Canada.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>British Columbia Centre for Excellence in HIV/AIDS, Vancouver, BC, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kendall</LastName>
<ForeName>Michelle</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Mathematics, Imperial College London, London, United Kingdom.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kühnert</LastName>
<ForeName>Denise</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Department of Environmental Systems Science, ETH Zürich, Zürich, Switzerland.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Department of Biosystems Science and Engineering, ETH Zürich, Basel, Switzerland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Leventhal</LastName>
<ForeName>Gabriel E</ForeName>
<Initials>GE</Initials>
<AffiliationInfo>
<Affiliation>Department of Environmental Systems Science, ETH Zürich, Zürich, Switzerland.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Department of Civil and Environmental Engineering, Massachusetts Institute of Technology (MIT), Cambridge, MA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Liang</LastName>
<ForeName>Richard</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>British Columbia Centre for Excellence in HIV/AIDS, Vancouver, BC, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Plazzotta</LastName>
<ForeName>Giacomo</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Department of Mathematics, Imperial College London, London, United Kingdom.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Poon</LastName>
<ForeName>Art F Y</ForeName>
<Initials>AF</Initials>
<AffiliationInfo>
<Affiliation>Department of Pathology & Laboratory Medicine, Western University, Ontario, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rasmussen</LastName>
<ForeName>David A</ForeName>
<Initials>DA</Initials>
<AffiliationInfo>
<Affiliation>Department of Biosystems Science and Engineering, ETH Zürich, Basel, Switzerland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Stadler</LastName>
<ForeName>Tanja</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Department of Biosystems Science and Engineering, ETH Zürich, Basel, Switzerland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Volz</LastName>
<ForeName>Erik</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Department of Infectious Disease Epidemiology, MRC Centre for Outbreak Analyses and Modelling, School of Public Health, Imperial College London, London, United Kingdom.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Weis</LastName>
<ForeName>Caroline</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Department of Biosystems Science and Engineering, ETH Zürich, Basel, Switzerland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Leigh Brown</LastName>
<ForeName>Andrew J</ForeName>
<Initials>AJ</Initials>
<AffiliationInfo>
<Affiliation>School of Biological Sciences, Institute of Evolutionary Biology, University of Edinburgh, Edinburgh, United Kingdom.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Fraser</LastName>
<ForeName>Christophe</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Department of Infectious Disease Epidemiology, MRC Centre for Outbreak Analyses and Modelling, School of Public Health, Imperial College London, London, United Kingdom.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Nuffield Department of Medicine, Li Ka Shing Centre for Health Information and Discovery, Oxford Big Data Institute, University of Oxford, Oxford, United Kingdom.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<CollectiveName>PANGEA-HIV Consortium</CollectiveName>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>MR/J013862/1</GrantID>
<Agency>Medical Research Council</Agency>
<Country>United Kingdom</Country>
</Grant>
<Grant>
<GrantID>U01 GM110749</GrantID>
<Acronym>GM</Acronym>
<Agency>NIGMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>UM1 AI068619</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2016</Year>
<Month>10</Month>
<Day>07</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Mol Biol Evol</MedlineTA>
<NlmUniqueID>8501455</NlmUniqueID>
<ISSNLinking>0737-4038</ISSNLinking>
</MedlineJournalInfo>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">HIV transmission and prevention</Keyword>
<Keyword MajorTopicYN="N">molecular epidemiology of infectious diseases</Keyword>
<Keyword MajorTopicYN="N">viral phylogenetic methods validation</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="entrez">
<Year>2017</Year>
<Month>1</Month>
<Day>6</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2017</Year>
<Month>1</Month>
<Day>6</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2017</Year>
<Month>1</Month>
<Day>6</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">28053012</ArticleId>
<ArticleId IdType="pii">msw217</ArticleId>
<ArticleId IdType="doi">10.1093/molbev/msw217</ArticleId>
</ArticleIdList>
</PubmedData>
</PubmedArticle>
<PubmedArticle>
<MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
<PMID Version="1">27990325</PMID>
<DateCreated>
<Year>2016</Year>
<Month>12</Month>
<Day>19</Day>
</DateCreated>
<DateRevised>
<Year>2017</Year>
<Month>03</Month>
<Day>23</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<JournalIssue CitedMedium="Print">
<Volume>4</Volume>
<PubDate>
<Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>EPJ data science</Title>
<ISOAbbreviation>EPJ Data Sci</ISOAbbreviation>
</Journal>
<ArticleTitle>Enhancing disease surveillance with novel data streams: challenges and opportunities.</ArticleTitle>
<ELocationID EIdType="pii" ValidYN="Y">17</ELocationID>
<Abstract>
<AbstractText>Novel data streams (NDS), such as web search data or social media updates, hold promise for enhancing the capabilities of public health surveillance. In this paper, we outline a conceptual framework for integrating NDS into current public health surveillance. Our approach focuses on two key questions: What are the opportunities for using NDS and what are the minimal tests of validity and utility that must be applied when using NDS? Identifying these opportunities will necessitate the involvement of public health authorities and an appreciation of the diversity of objectives and scales across agencies at different levels (local, state, national, international). We present the case that clearly articulating surveillance objectives and systematically evaluating NDS and comparing the performance of NDS to existing surveillance data and alternative NDS data is critical and has not sufficiently been addressed in many applications of NDS currently in the literature.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Althouse</LastName>
<ForeName>Benjamin M</ForeName>
<Initials>BM</Initials>
<AffiliationInfo>
<Affiliation>Santa Fe Institute, Santa Fe, NM, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Scarpino</LastName>
<ForeName>Samuel V</ForeName>
<Initials>SV</Initials>
<AffiliationInfo>
<Affiliation>Santa Fe Institute, Santa Fe, NM, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Meyers</LastName>
<ForeName>Lauren Ancel</ForeName>
<Initials>LA</Initials>
<AffiliationInfo>
<Affiliation>Santa Fe Institute, Santa Fe, NM, USA.; The University of Texas at Austin, Austin, TX, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ayers</LastName>
<ForeName>John W</ForeName>
<Initials>JW</Initials>
<AffiliationInfo>
<Affiliation>San Diego State University, San Diego, CA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bargsten</LastName>
<ForeName>Marisa</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>New Mexico Department of Health, Santa Fe, NM, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Baumbach</LastName>
<ForeName>Joan</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>New Mexico Department of Health, Santa Fe, NM, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Brownstein</LastName>
<ForeName>John S</ForeName>
<Initials>JS</Initials>
<AffiliationInfo>
<Affiliation>Children's Hospital Informatics Program, Boston Children's Hospital, Boston, MA, USA.; Department of Pediatrics, Harvard Medical School, Boston, MA, USA.; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Castro</LastName>
<ForeName>Lauren</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Defense Systems and Analysis Division, Los Alamos National Laboratory, Los Alamos, NM, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Clapham</LastName>
<ForeName>Hannah</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cummings</LastName>
<ForeName>Derek At</ForeName>
<Initials>DA</Initials>
<AffiliationInfo>
<Affiliation>Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Del Valle</LastName>
<ForeName>Sara</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Defense Systems and Analysis Division, Los Alamos National Laboratory, Los Alamos, NM, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Eubank</LastName>
<ForeName>Stephen</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Virginia BioInformatics Institute and Department of Population Health Sciences, Virginia Tech, Blacksburg, VA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Fairchild</LastName>
<ForeName>Geoffrey</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Defense Systems and Analysis Division, Los Alamos National Laboratory, Los Alamos, NM, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Finelli</LastName>
<ForeName>Lyn</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Generous</LastName>
<ForeName>Nicholas</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Defense Systems and Analysis Division, Los Alamos National Laboratory, Los Alamos, NM, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>George</LastName>
<ForeName>Dylan</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Biomedical Advanced Research and Development Authority (BARDA), Assistant Secretary for Preparedness and Response (ASPR), Department of Health and Human Services, Washington, DC, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Harper</LastName>
<ForeName>David R</ForeName>
<Initials>DR</Initials>
<AffiliationInfo>
<Affiliation>Chatham House, 10 St James's Square, London, SW1Y 4LE, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hébert-Dufresne</LastName>
<ForeName>Laurent</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Santa Fe Institute, Santa Fe, NM, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Johansson</LastName>
<ForeName>Michael A</ForeName>
<Initials>MA</Initials>
<AffiliationInfo>
<Affiliation>Division of Vector-Borne Diseases, NCEZID, Centers for Disease Control and Prevention, San Juan, PR, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Konty</LastName>
<ForeName>Kevin</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Division of Epidemiology, New York City Department of Health and Mental Hygiene, New York, NY, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lipsitch</LastName>
<ForeName>Marc</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Communicable Disease Dynamics, Harvard School of Public Health, Boston, MA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Milinovich</LastName>
<ForeName>Gabriel</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>School of Population Health, The University of Queensland, Brisbane, QLD, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Miller</LastName>
<ForeName>Joseph D</ForeName>
<Initials>JD</Initials>
<AffiliationInfo>
<Affiliation>Division of Vector-Borne Diseases, NCEZID, Centers for Disease Control and Prevention, Atlanta, GA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nsoesie</LastName>
<ForeName>Elaine O</ForeName>
<Initials>EO</Initials>
<AffiliationInfo>
<Affiliation>Children's Hospital Informatics Program, Boston Children's Hospital, Boston, MA, USA.; Department of Pediatrics, Harvard Medical School, Boston, MA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Olson</LastName>
<ForeName>Donald R</ForeName>
<Initials>DR</Initials>
<AffiliationInfo>
<Affiliation>Division of Epidemiology, New York City Department of Health and Mental Hygiene, New York, NY, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Paul</LastName>
<ForeName>Michael</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Computer Science, Johns Hopkins University, Baltimore, MD, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Polgreen</LastName>
<ForeName>Philip M</ForeName>
<Initials>PM</Initials>
<AffiliationInfo>
<Affiliation>University of Iowa, Iowa City, IA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Priedhorsky</LastName>
<ForeName>Reid</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Defense Systems and Analysis Division, Los Alamos National Laboratory, Los Alamos, NM, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Read</LastName>
<ForeName>Jonathan M</ForeName>
<Initials>JM</Initials>
<AffiliationInfo>
<Affiliation>Department of Epidemiology and Population Health, Institute of Infection and Global Health, University of Liverpool, Liverpool, CH64 7TE, UK.; Health Protection Research Unit in Emerging and Zoonotic Infections, NIHR, Liverpool, L69 7BE, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rodríguez-Barraquer</LastName>
<ForeName>Isabel</ForeName>
<Initials>I</Initials>
<AffiliationInfo>
<Affiliation>Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Smith</LastName>
<ForeName>Derek J</ForeName>
<Initials>DJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Zoology, University of Cambridge, Cambridge, CB2 3EJ, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Stefansen</LastName>
<ForeName>Christian</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Google Inc., Mountain View, CA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Swerdlow</LastName>
<ForeName>David L</ForeName>
<Initials>DL</Initials>
<AffiliationInfo>
<Affiliation>National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Thompson</LastName>
<ForeName>Deborah</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>New Mexico Department of Health, Santa Fe, NM, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Vespignani</LastName>
<ForeName>Alessandro</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Laboratory for the Modeling of Biological and Socio-technical Systems, Northeastern University, Boston, MA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wesolowski</LastName>
<ForeName>Amy</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Communicable Disease Dynamics, Harvard School of Public Health, Boston, MA, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R01 GM109718</GrantID>
<Acronym>GM</Acronym>
<Agency>NIGMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U54 GM088558</GrantID>
<Acronym>GM</Acronym>
<Agency>NIGMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>10</Month>
<Day>16</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Germany</Country>
<MedlineTA>EPJ Data Sci</MedlineTA>
<NlmUniqueID>101686785</NlmUniqueID>
<ISSNLinking>2193-1127</ISSNLinking>
</MedlineJournalInfo>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Comput Biol. 2013;9(10):e1003256</RefSource>
<PMID Version="1">24146603</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Clin Infect Dis. 2014 Nov 15;59(10):1446-50</RefSource>
<PMID Version="1">25115873</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>MMWR Morb Mortal Wkly Rep. 2014 May 23;63(20):441-5</RefSource>
<PMID Version="1">24848215</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2013 May 30;8(5):e64323</RefSource>
<PMID Version="1">23750192</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2012;7(8):e43611</RefSource>
<PMID Version="1">22952719</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Negl Trop Dis. 2011 Aug;5(8):e1258</RefSource>
<PMID Version="1">21829744</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>JAMA. 2014 Apr 9;311(14):1399-400</RefSource>
<PMID Version="1">24577162</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Natl Cancer Inst Monogr. 2013 Dec;2013(47):188-94</RefSource>
<PMID Version="1">24395990</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Prev Med. 2014 Sep;47(3):341-7</RefSource>
<PMID Version="1">24997572</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nature. 2009 Feb 19;457(7232):1012-4</RefSource>
<PMID Version="1">19020500</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nicotine Tob Res. 2014 May;16(5):576-83</RefSource>
<PMID Version="1">24323570</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Prev Med. 2014 Feb;46(2):166-70</RefSource>
<PMID Version="1">24439350</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Med Internet Res. 2014 Jan 22;16(1):e22</RefSource>
<PMID Version="1">24451921</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Prev Med. 2014 Jan;58:81-4</RefSource>
<PMID Version="1">24252489</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Clin Infect Dis. 2008 Dec 1;47(11):1443-8</RefSource>
<PMID Version="1">18954267</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2010 Nov 29;5(11):e14118</RefSource>
<PMID Version="1">21124761</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>MMWR Suppl. 2005 Aug 26;54:41-6</RefSource>
<PMID Version="1">16177692</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Curr. 2011 Aug 02;3:RRN1251</RefSource>
<PMID Version="2">21894257</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Clin Infect Dis. 2007 Jan 15;44(2):272-9</RefSource>
<PMID Version="1">17173231</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Comput Biol. 2014 Apr 17;10(4):e1003581</RefSource>
<PMID Version="1">24743682</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lancet Infect Dis. 2014 Feb;14(2):160-8</RefSource>
<PMID Version="1">24290841</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2013 Dec 09;8(12):e83672</RefSource>
<PMID Version="1">24349542</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Comput Biol. 2014 Nov 13;10(11):e1003892</RefSource>
<PMID Version="1">25392913</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Clin Microbiol Infect. 2014 Jan;20(1):17-21</RefSource>
<PMID Version="1">24350723</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 2014 Mar 14;343(6176):1203-5</RefSource>
<PMID Version="1">24626916</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Am Med Inform Assoc. 2008 Mar-Apr;15(2):150-7</RefSource>
<PMID Version="1">18096908</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2011 Mar 16;6(3):e16777</RefSource>
<PMID Version="1">21436883</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Comput Biol. 2012;8(4):e1002472</RefSource>
<PMID Version="1">22511860</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">digital surveillance</Keyword>
<Keyword MajorTopicYN="N">disease surveillance</Keyword>
<Keyword MajorTopicYN="N">novel data streams</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="entrez">
<Year>2016</Year>
<Month>12</Month>
<Day>20</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2015</Year>